Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

568
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
568
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K
Introduction to Hemostasis01:05

Introduction to Hemostasis

4.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K
Coagulation01:09

Coagulation

3.7K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
3.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same authorSame journal

Risk factor obesity: Treatment Standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Trial End Points in ANCA-Associated Vasculitis: Are We Missing the Boat?

Journal of the American Society of Nephrology : JASN·2026
Same author

Development and validation of EULAR quality indicators for lupus nephritis: adherence trends and impact on clinical outcomes.

Annals of the rheumatic diseases·2026
Same author

Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

RMD open·2026
Same author

Cost-effectiveness of the sFlt-1/PlGF ratio and telemonitoring in managing suspected pre-eclampsia: protocol for the PREPARE II randomised controlled trial.

BMJ open·2026

相关实验视频

Updated: May 16, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K

在二次血栓性微血管病变中补充激活.

Johann Morelle1,2, Fernando Caravaca-Fontan3, Fadi Fakhouri4

  • 1University Hospitals Namur (CHU UCL Namur), Namur, Belgium.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
|May 15, 2025
PubMed
概括

二次性血栓性微血管病变 (TMA) 涉及补体失调. 补充抑制对严重或耐火病例有希望,改善这些高风险脏疾病的结果.

关键词:
急性脏损伤急性脏损伤补充抑制是补充的抑制.互补系统是互补的系统.血溶性尿素性综合征是什么血栓性微血管病变是一种血栓性微血管病变.

更多相关视频

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.4K
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.4K

相关实验视频

Last Updated: May 16, 2025

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.4K
Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells
06:29

Methods for Quantitative Detection of Antibody-induced Complement Activation on Red Blood Cells

Published on: January 29, 2014

30.4K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 血液学 血液学 血液学
  • 免疫学 免疫学 免疫学

背景情况:

  • 二次性血栓性微血管病变 (TMA) 是一种严重的疾病,具有高衰竭和死亡风险.
  • 补充失调越来越多地与二次TMA的发展有关.
  • 目前的治疗方法取得的成功有限,需要新的治疗方法.

研究的目的:

  • 审查目前对二次TMA病原和管理的理解.
  • 突出补充失调在各种二次TMA形式中的作用.
  • 强调补充抑制的治疗潜力.

主要方法:

  • 对二次TMA和补充途径研究的文献综述.
  • 分析证据,将补充基因变异与特定的TMA亚型联系起来.
  • 评估与补充抑制疗法相关的临床结果.

主要成果:

  • 某些二次TMA形式 (产后,移植相关,严重高血压) 显示补充基因变异,表明补充介导机制.
  • 早期补充抑制对于管理这些特定的TMA类型至关重要.
  • 补充激活也可能导致其他二次TMA病因,即使没有明显的基因变异.

结论:

  • 补充失调是许多二次TMA的关键因素.
  • 补充抑制剂为严重或耐火的二次TMA提供了有希望的治疗策略.
  • 需要进一步的研究和临床试验来优化补充抑制的使用.